| 英文别名 |
Bicalutamide;Bicalutamide (Subject to patent free);4-cyano-3-trifluoromethyl-N-(3-p-fluorophenylsulfonyl-2-hydroxy-2-methylpropionyl)aniline;N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamid;Bicalutamidec;Bicalutumide (CDX, ICI 176334, Casodex®, Cosudex®, Calutide®, Kalumid®);Bicaiutamide;BicalutaMide API;Cosudex;ODEX;Bicalutamide (CDX);Casodex;N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide;N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropionamide;N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamide;Calutide;ICI 176334;N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide;Bicalutamide (Casodex);LKJPYSCBVHEWIU-UHFFFAOYSA-N;(+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide;C18H14F4N2O4S;ICI 176,334;CPD000466329;Propanami;N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide (ACI);Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-, (±)- (ZCI);(±)-4′-Cyano-α,α,α-trifluoro-3-[(p-fluorophenyl)sulfonyl]-2-methyl-m-lactotoluidide;Casode;ZD 176334;Bicalutamide for system suitability;AC-4232;Bicusan;bicalutamida;NCGC00167977-02;HMS3654K18;CCRIS 8728;EX-A962;D00961;BICALUTAMIDE [USP MONOGRAPH];Bicalutamide, British Pharmacopoeia (BP) Reference Standard;Tox21_303560;Calumid;Z2108698963;SDCCGSBI-0633779.P001;BICALUTAMIDE [USAN];BICALUTAMIDE (MART.);Bicalutamide for system suitability, European Pharmacopoeia (EP) Reference Standard;LP01026;4'-cyano-3-[(4- fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'-trifluoromethylpropionanilide;BICALUTAMIDE [EP MONOGRAPH];NSC722665;NSC-722665;HMS3263M13;NCGC00261711-01;PROPANAMIDE, N-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)-3-((4-FLUOROPHENYL)SULFONYL)-2-HYDROXY-2-METHYL-, (+/-)-;rac-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methylpropanamide;4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide;SR-01000759410-4;(+-)-bicalutamide;BDBM18525;HSDB 7655;HMS3714P13;NC00201;Propanamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-, (+-)-;Q1988832;HMS2051B13;(+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p- fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide;N-(4-Cyano-3-(trifluoromethyl)phenyl)3-3((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-propanamide;BICALUTAMIDE (USP IMPURITY);AB00639963_10;NCGC00257459-01;CCG-220876;CCG-100951;L02BB03;Casodex (TN);NS00000400;AB00639963-08;N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methylpropanamide;CHEBI:91617;BRD-A29485665-001-11-0;BICALUTAMIDE (EP MONOGRAPH);SB17301;90357-06-5;MLS001... |